Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Respiri addresses cash burn by targeting cheaper labour in The Philippines

  • In News
  • September 28, 2022
  • Alinda Gupta
Respiri addresses cash burn by targeting cheaper labour in The Philippines

After less than satisfactory ventures in India and the USA, medtech company dedicated to respiratory health Respiri (ASX: RSH) is heading to the Philippines. The Company will establish a Company Centre of Digital Innovation Excellence, which will aim to drive digital product innovation to cater to American market opportunities, improve productivity and increase return on investment.

This initiative is expected to reduce Respiri’s IT costs by $700,000 per annum and increase productivity by about 30%. The Philippines’ employment market is brimming with tier 1 software engineering resources, which are highly skilled and more affordable than others. This gives Respiri plenty of access to useful resources. As part of the initiative, the Company’s Australian-based IT human resources will be eligible for R&D tax credits.

In the initial phase, the Company opted for an Employer of Record business model in the Philippines, with support from local partner Yempo Solutions, to get employees on board. In September 2022, Respiri finished hiring the first bunch of new staff, totaling eight employees. These resources complement Respiri’s existing Customer Service function which had been established via the same business model in late 2021. 

Respiri CEO, Marjan Mikel, commented, “We are taking strategic steps in bringing critical capabilities inhouse and establishing core competencies that are central to Respiri’s business model. The newly established Centre of Excellence will accelerate our digital design and development capabilities and allow further improvements in productivity and efficiency through its low-cost location.”

Mikel acknowledges that the Philippines is allowing them to tap into a very capable talent pool to meet customer requirements. The Philippines expansion follows an internal review of strategic competences required to support Respiri’s global growth ambitions, which it previously tried to achieve by setting up shop in India and USA. 

To do so, the Company believes that it must prioritise in house key tech competencies and processes, with special attention to research and development. In fact, it started operating an in-house processing structure in September 2022. Its growth agenda also entails partnering with technology vendors and service providers to drive cost reductions and increase productivity. Resources will focus on mobile and web apps, web portals, SaaS, Machine Learning, system integration and API, as well as full platform and IT ecosystem solutions. 

As these resources are in the same time zone as key local product development resources, the Company is able to create a collaborative work environment. The Centre of Excellence will undertake the design and development of software underpinning digital products and technology solutions. 

Through this initiative, Respiri aims to reduce its cash burn and increase development capacity. This way, it will be able to make the most of market opportunities unlike before. Respiri seems to be extremely committed to gaining ground in the USA. Besides this initiative, on September 21, 2022, the Company completed a placement of $1.6 million to sophisticated investors with management providing $100,000 to support the Company’s growth in America.

Respiri CTO George Vlachodimitropoulos concluded, “To support the USA market strategy Respiri has recast the technology operating model to support revenue growth opportunities, develop market aligned products in a more collaborative manner, gain productivity improvements and improve cost structures.”

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • centre of excellence
  • George Vlachodimitropoulos
  • Marjan Mikel
  • r and d
  • Respiri
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.